Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Long-Term Safety Considerations The absence of long-term human safety data represents the most significant knowledge gap around BPC-157
In experimental models it modulates angiogenesis (upregulating VEGF/VEGFR2 and the nitric oxide pathway), reduces pro-inflammatory cytokine signaling, supports fibroblast migration and collagen synthesis for connective-tissue repair, and influences gut-barrier integrity and neural pathways mechanisms that span musculoskeletal, gastrointestinal, and neurological tissue in preclinical research
A standard KLOW cycle lasts 12 weeks, followed by 48 weeks off
BPC-157 + TB-500 5+5mg Pre-blended vial containing BPC-157 (Body Protection Compound, a 15 amino acid pentadecapeptide) and TB-500 (a synthetic fragment of thymosin beta-4)
US$ 29.08
US$ 24.66
US$ 27.60
US$ 28.57
US$ 28.84
US$ 29.43
US$ 29.77
US$ 28.00
